【产品介绍】：

产品名称 Riociguat 英文名称 Riociguat 应用 Riociguat (BAY 63-2521)是可溶的鸟苷酸环化酶刺激剂。 规格或纯度 ≥99% 别名 利奥西呱 英文别名 BAY 63-2521; BAY 632521;N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methylcarbamic acid methyl ester 运输条件 干冰运输 生化机理 Riociguat (BAY 63-2521; BAY 632521) is a novel drμg that is currently in clinical development by Bayer. Riociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC). At the moment Phase III clinical trials investigate the use of riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drμg of a novel class of sGC stimulators.CAS编号 625115-55-1 溶解性 DMSO 储存温度 −20°C 分子量 422.42 分子式 C20H19FN8O2 PubChem CID 11304743